Search

everythinglearnresearchcommunity

for

Search:↓

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Retinol palmitate may reduce cancer relapses in early-stage lung cancer patients.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

A specific hair diffraction pattern may indicate breast cancer if tested with the correct method.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Pranic meditation significantly improved mental health and quality of life for breast cancer survivors.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

Hair loss gene linked to prostate issues.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

Removing lymph nodes does not improve survival for advanced ovarian cancer and may cause more complications.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Higher DHT in male baldness may protect against prostate cancer.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Women who had cancer treatment feel both positive and negative about their bodies.

Bald men may have a lower risk of testicular cancer.

Women with alopecia may have a higher chance of getting thyroid cancer.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.